Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”

Ling-Yue ZhaoDepartment of Ambulatory Surgery, Shenzhen Nanshan District People’s Hospital, Shenzhen, Guangdong 518052, People’s Republic of China, [email protected]

Yi-Jun LuoDepartment of Ambulatory Surgery, Shenzhen Nanshan District People’s Hospital, Shenzhen, Guangdong 518052, People’s Republic of China, [email protected]Correspondence[email protected]

Jing ZhuDepartment of Ambulatory Surgery, Shenzhen Nanshan District People’s Hospital, Shenzhen, Guangdong 518052, People’s Republic of China, [email protected]

References

ArmaniniDFioreCChoice of diuretic therapy and reconsideration for aldosterone receptors blockersHypertension2010551e519948981
PubMed Web of Science ®Google Scholar
ArmaniniDSabbadinCDonàGClariGBordinLAldosterone receptor blockers spironolactone and canrenone: two multivalent drugsExpert Opin Pharmacother201415790991224617854
PubMed Web of Science ®Google Scholar
DerosaGGaudioGPasiniGD’AngeloAMaffioliPA randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patientsDrug Des Devel Ther20181226112616
PubMed Web of Science ®Google Scholar
American Diabetes Association6. Glycemic targets: standards of medical care in diabetes-2018Diabetes Care201841Suppl 1S55S6429222377
PubMed Web of Science ®Google Scholar
CatapanoALGrahamIDe BackerG2016 ESC/EAS guidelines for the management of dyslipidaemiasEur Heart J201637392999305827567407
PubMed Web of Science ®Google Scholar
SchmidtMMansfieldKEBhaskaranKSerum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort studyBMJ2017356j79128279964
PubMed Web of Science ®Google Scholar

Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date